Compare SIGI & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SIGI | TFX |
|---|---|---|
| Founded | 1926 | 1943 |
| Country | United States | United States |
| Employees | 2800 | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.3B |
| IPO Year | N/A | 1994 |
| Metric | SIGI | TFX |
|---|---|---|
| Price | $89.33 | $129.62 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $85.80 | ★ $138.75 |
| AVG Volume (30 Days) | 423.5K | ★ 709.9K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.03% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $0.41 | $15.97 |
| Revenue Next Year | $4.81 | $5.15 |
| P/E Ratio | $11.38 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $71.75 | $100.18 |
| 52 Week High | $91.65 | $139.67 |
| Indicator | SIGI | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 61.93 | 51.07 |
| Support Level | $76.34 | $117.57 |
| Resistance Level | $91.31 | $134.84 |
| Average True Range (ATR) | 2.22 | 4.28 |
| MACD | 0.22 | -0.31 |
| Stochastic Oscillator | 69.14 | 27.05 |
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.